• Amanda Helip-Wooley
  • Robert Kleta
  • William A. Gahl


Bartter Syndrome Nephropathic Cystinosis Renal Fanconi Syndrome Cystine Content Cystinosis Patient 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. Abderhalden, E., 1903, Familiäre Cystindiathese, Hoppe Seylers Zeitschr. f. physiol. Chemie. 38:557-561.Google Scholar
  2. Andrews, P. A., Sacks, S. H., and Van’t Hoff, W., 1994, Successful pregnancy in cystinosis, JAMA 272:1327-1328.CrossRefPubMedGoogle Scholar
  3. Anikster, Y., Lacbawan, F., Brantly, M., Gochuico, B. L., Avila, N. A., Travis, W., and Gahl, W. A., 2001, Pulmonary dysfunction in adults with nephropathic cystinosis, Chest. 119:394-401.CrossRefPubMedGoogle Scholar
  4. Anikster, Y., Lucero, C., Guo, J., Huizing, M., Shotelersuk, V., Bernardini, I., McDowell, G., Iwata, F., Kaiser-Kupfer, M. I., Jaffe, R., Thoene, J., Schneider, J. A., and Gahl, W. A., 2000, Ocular nonnephropathic cystinosis: Clinical, biochemical, and molecular correlations, Pediatr. Res. 47:17-23.CrossRefPubMedGoogle Scholar
  5. Anikster, Y., Lucero, C., Touchman, J. W., Huizing, M., McDowell, G., Shotelersuk, V., Green, E. D., and Gahl, W. A., 1999, Identification and detection of the common 65-kb deletion breakpoint in the nephropathic cystinosis gene (CTNS), Mol. Genet. Metab. 66:111-116.CrossRefPubMedGoogle Scholar
  6. Assadi, F. K., McCue, P., Jefferis, S., Shi, M., and Beckman, D. A., 1999, Effects of pre-and postnatal cysteamine exposure on renal function in the rat, Pediatr. Nephrol. 13:812-815.CrossRefPubMedGoogle Scholar
  7. Assadi, F. K., Mullin, J. J., and Beckman, D. A., 1998, Evaluation of the reproductive and developmental safety of cysteamine in the rat: Effects on female reproduction and early embryonic development, Teratology 58:88-95.CrossRefPubMedGoogle Scholar
  8. Attard, M., Jean, G., Forestier, L., Cherqui, S., van’t Hoff, W., Broyer, M., Antignac, C., and Town, M., 1999, Severity of phenotype in cystinosis varies with mutations in the CTNS gene: predicted effect on the model of cystinosin, Hum. Mol. Genet. 8:2507-2514.CrossRefPubMedGoogle Scholar
  9. Beckman, D. A., Mullin, J. J., and Assadi, F. K., 1998, Developmental toxicity of cysteamine in the rat: effects on embryo-fetal development, Teratology 58:96-102.CrossRefPubMedGoogle Scholar
  10. Belldina, E. B., Huang, M. Y., Schneider, J. A., Brundage, R. C., and Tracy, T. S., 2003, Steady-state pharmacokinetics and pharmacodynamics of cysteamine bitartrate in paediatric nephropathic cystinosis patients, Br. J. Clin. Pharmacol. 56:520-525.CrossRefPubMedGoogle Scholar
  11. Bendavid, C., Kleta, R., Long, R., Ouspenskaia, M., Muenke, M., Haddad, B. R., and Gahl, W. A., 2004, FISH diagnosis of the common 57-kb deletion in CTNS causing cystinosis, Human Genet. 115:510-514.CrossRefGoogle Scholar
  12. Bickel, H., 1955, Die Entwicklung der biochemischen Läsion bei der Lignac-Fanconischen Krankheit, Helv. Paed. Acta 10:259-268.Google Scholar
  13. Cetinkaya, I., Schlatter, E., Hirsch, J. R., Herter, P., Harms, E., and Kleta, R., 2002, Inhibition of Na(+)-dependent transporters in cystine-loaded human renal cells: electrophysiological studies on the Fanconi syndrome of cystinosis, J. Am. Soc. Nephrol. 13:2085-2093.CrossRefPubMedGoogle Scholar
  14. Charnas, L. R., Luciano, C. A., Dalakas, M.,Gilliatt, R. W., Bernardini, I., Ishak, K., Cwik, V. A., Fraker, D., Brushart, T. A., and Gahl, W. A., 1994, Distal vacuolar myopathy in nephropathic cystinosis, Ann. Neurol. 35:181-188.CrossRefPubMedGoogle Scholar
  15. Cherqui, S., Kalatzis, V., Trugnan, G., and Antignac, C., 2001, The targeting of cystinosin to the lysosomal membrane requires a tyrosine-based signal and a novel sorting motif, J. Biol. Chem. 276:13314-13321.CrossRefPubMedGoogle Scholar
  16. Cherqui, S., Sevin, C., Hamard, G., Kalatzis, V., Sich, M., Pequignot, M. O., Gogat, K., Abitbol, M., Broyer, M., Gubler, M. C., and Antignac, C., 2002, Intralysosomal cystine accumulation in mice lacking cystinosin, the protein defective in cystinosis, Mol. Cell. Biol. 22:7622-7632.CrossRefPubMedGoogle Scholar
  17. Chik, C. L., Friedman, A., Merriam, G. R., and Gahl, W. A., 1993, Pituitary-testicular function in nephropathic cystinosis, Ann. Intern. Med. 119:568-575.PubMedGoogle Scholar
  18. Corden, B. J., Schulman, J. D., Schneider, J. A., and Thoene, J. G., 1981, Adverse reactions to oral cysteamine use in nephropathic cystinosis, Dev. Pharmacol. Ther. 3:25-30.PubMedGoogle Scholar
  19. Da Silva, V. A., Zurbrugg, R. P., Lavanchy, P., Blumberg, A., Suter, H., Wyss, S. R., Luthy, C. M., and Oetliker, O. H., 1985, Long-term treatment of infantile nephropathic cystinosis with cysteamine, N. Engl. J. Med. 313:1460-1463.PubMedGoogle Scholar
  20. Debre, R., Marie, J., Cleret, F., Messimy, R., 1934, Rachitisme tardif coexistant avec une nephrite chronique et une glycosurie. Archives de Médecine des Enfants, 37:597-606.Google Scholar
  21. De Duve, C., Pressman, B. C., Gianetto, R., Wattiaux, R., and Appelmans, F., 1955, Tissue fractionation studies. 6. Intracellular distribution patterns of enzymes in rat-liver tissue, Biochem. J. 60:604-617.PubMedGoogle Scholar
  22. De Toni, G., 1933, Remarks on the relations between renal rickets (renal dwarfism) and renal diabetes, Acta Paediatrica, 16:479-484.CrossRefGoogle Scholar
  23. Dogulu, C. F., Tsilou, E., Rubin, B., Fitzgibbon, E. J., Kaiser-Kupfer, M. I., Rennert, O. M., and Gahl, W. A., 2004, Idiopathic intracranial hypertension in cystinosis, J. Pediatr. 145:673-678.CrossRefPubMedGoogle Scholar
  24. Dohil, R., Fidler, M., Barshop, B., Newbury, R., Sellers, Z., Deutsch, R., and Schneider, J., 2005, Esomeprazole therapy for gastric acid hypersecretion in children with cystinosis, Pediatr. Nephrol. 20:1786-1793.CrossRefPubMedGoogle Scholar
  25. Dohil, R., Newbury, R. O., Sellers, Z. M., Deutsch, R., and Schneider, J. A., 2003, The evaluation and treatment of gastrointestinal disease in children with cystinosis receiving cysteamine, J. Pediatr. 143:224-230.CrossRefPubMedGoogle Scholar
  26. Ehrich, J. H., Stoeppler, L., Offner, G., and Brodehl, J., 1979, Evidence for cerebral involvement in nephropathic cystinosis, Neuropadiatrie 10:128-137.CrossRefPubMedGoogle Scholar
  27. Fanconi, G., 1936, Der frühinfantile nephrotisch-glykosurische Zwergwuchs mit hypo-phosphatämischer Rachitis, Jahrbuch für Kinderheilkunde, 147:299-338.Google Scholar
  28. Fink, J. K., Brouwers, P., Barton, N., Malekzadeh, M. H., Sato, S., Hill, S., Cohen, W. E., Fivush, B., and Gahl, W. A., 1989, Neurologic complications in long-standing nephro-pathic cystinosis, Arch. Neurol. 46:543-548.PubMedGoogle Scholar
  29. Fivush, B., Flick, J. A., and Gahl, W. A., 1988, Pancreatic exocrine insufficiency in a patient with nephropathic cystinosis, J. Pediatr. 112:49-51.CrossRefPubMedGoogle Scholar
  30. Fivush, B., Green, O. C., Porter, C. C., Balfe, J. W., O’Regan, S., and Gahl, W. A., 1987, Pancreatic endocrine insufficiency in posttransplant cystinosis, Am. J. Dis. Child. 141:1087-1089.PubMedGoogle Scholar
  31. Forestier, L., Jean, G., Attard, M., Cherqui, S., Lewis, C., van't Hoff, W., Broyer, M., Town, M., and Antignac, C., 1999, Molecular characterization of CTNS deletions in nephropathic cystinosis: Development of a PCR-based detection assay, Am. J. Hum. Genet. 65:353-359.CrossRefPubMedGoogle Scholar
  32. Gahl, W. A., 1986, Cystinosis coming of age, Adv. Pediatr. 33:95-126.PubMedGoogle Scholar
  33. Gahl, W. A., 2003, Early oral cysteamine therapy for nephropathic cystinosis, Eur. J. Pediatr. 162(Suppl. 1):S38-S41.CrossRefPubMedGoogle Scholar
  34. Gahl, W. A., Bashan, N., Tietze, F., and Schulman, J. D., 1984, Lysosomal cystine counter-transport in heterozygotes for cystinosis, Am J. Hum. Genet. 36:277-282.PubMedGoogle Scholar
  35. Gahl, W. A., Bashan, N., Tietze, F., Bernardini, I., and Schulman, J. D., 1982a, Lysosomal cystine transport is defective in cystinosis, Science 217:1263-1265.CrossRefGoogle Scholar
  36. Gahl, W. A., Charnas, L., Markello, T. C., Bernardini, I., Ishak, K. G., and Dalakas, M. C., 1992, Parenchymal organ cystine depletion with long-term cysteamine therapy, Biochem. Med. Metab. Biol. 48:275-285.CrossRefPubMedGoogle Scholar
  37. Gahl, W. A., Dalakas, M. C., Charnas, L., Chen, K. T., Pezeshkpour, G. H., Kuwabara, T., Davis, S. L., Chesney, R. W., Fink, J., and Hutchison, H. T., 1988, Myopathy and cystine storage in muscles in a patient with nephropathic cystinosis, N. Engl. J. Med. 319:1461-1464.PubMedGoogle Scholar
  38. Gahl, W. A., Kuehl, E. M., Iwata, F., Lindblad, A., and Kaiser-Kupfer, M. I., 2000, Corneal crystals in nephropathic cystinosis: Natural history and treatment with cyste-amine eyedrops, Mol. Genet. Metab. 71:100-120.CrossRefPubMedGoogle Scholar
  39. Gahl, W. A., Reed, G. F., Thoene, J. G., Schulman, J. D., Rizzo, W. B., Jonas, A. J., Denman, D. W., Schlesselman, J. J., Corden, B. J., and Schneider, J. A., 1987, Cysteamine therapy for children with nephropathic cystinosis, N. Engl. J. Med. 316:971-977.PubMedCrossRefGoogle Scholar
  40. Gahl, W. A., Thoene, J., and Schneider, J. A., 2001, Cystinosis: A Disorder of Lysosomal Membrane Transport, in: The Metabolic & Molecular Bases of Inherited Disease, C. R. Scriver, A. L. Beaudet, D. Valle, W. S. Sly, Eds., McGraw-Hill, New York, pp. 5085-5108.Google Scholar
  41. Gahl, W. A, Thoene, J. G., and Schneider, J. A., 2002, Cystinosis, N. Engl. J. Med. 347:111-121.CrossRefGoogle Scholar
  42. Gahl, W. A., Tietze, F., Bashan, N., Bernardini, I., Raiford, D., and Schulman, J. D., 1983, Characteristics of cystine counter-transport in normal and cystinotic lysosome-rich leucocyte granular fractions, Biochem. J. 216:393-400.PubMedGoogle Scholar
  43. Gahl, W. A., Tietze, F., Bashan, N., Steinherz, R., and Schulman, J. D., 1982b, Defective cystine exodus from isolated lysosome-rich fractions of cystinotic leucocytes, J. Biol. Chem. 257:9570-9575.Google Scholar
  44. Gahl, W. A., Tietze, F., Butler, J. D., and Schulman, J. D., 1985, Cysteamine depletes cystinotic leucocyte granular fractions of cystine by the mechanism of disulphide interchange, Biochem. J. 228:545-550.PubMedGoogle Scholar
  45. Gretz, N., Manz, F., Augustin, R., Barrat, T. M., Bender-Gotze, C., Brandis, M., Bremer, H. J., Brodehl, J., Broyer, M., Bulla, M., Callis, L., Chantler, C., Diekmann, L., Dillon, M. J., Egli, F., Ehrich, J. H., Endres, W., Fanconi, A., Feldhoff, C., Geisert, J., Gekle, D., Gescholl-Bauer, B., Grote, K., Gruttner, R., Hagge, W., Haycock, C. B., Hennemann, H., Klare, B., Leupold, D., Lohr, H., Michalk, D., Oliveira, A., Ott, F., Pistor, K., Rau, J., Scharer, K., Schindera, F., Schmidt, H., Schulte-Wissermann, H., Verrier-Jones, K., Weber, H. P., Willenbockel, U., and Wolf, H., 1983, Survival time in cystinosis. A collaborative study, Proc. Eur. Dial. Transplant. Assoc. 19:582-589.PubMedGoogle Scholar
  46. Haq, M. R., Kalatzis, V., Gubler, M. C., Town, M. M., Antignac, C., Van't Hoff, W. G., and Woolf, A. S., 2002, Immunolocalization of cystinosin, the protein defective in cystinosis, J. Am. Soc. Nephrol. 13:2046-2051.CrossRefPubMedGoogle Scholar
  47. Helip-Wooley, A., Park, M. A., Lemons, R. M., and Thoene, J. G., 2002, Expression of CTNS alleles: subcellular localization and aminoglycoside correction in vitro, Mol. Genet. Metab. 75:128-133.CrossRefPubMedGoogle Scholar
  48. Iwata, F., Kuehl, E. M., Reed, G. F., McCain, L. M., Gahl, W. A., and Kaiser-Kupfer, M. I., 1998, A randomized clinical trial of topical cysteamine disulfide (cystamine) versus free thiol (cysteamine) in the treatment of corneal cystine crystals in cystinosis, Mol. Genet. Metab. 64:237-242.CrossRefPubMedGoogle Scholar
  49. Jonas, A. J., Greene, A. A., Smith, M. L., and Schneider, J.A., 1982, Cystine accumu-lation and loss in normal, heterozygous, and cystinotic fibroblasts, Proc. Natl. Acad. Sci. USA 79:4442-4445.CrossRefPubMedGoogle Scholar
  50. Kaiser-Kupfer, M. I., Caruso, R. C., Minkler, D. S., and Gahl, W. A., 1986, Long-term ocular manifestations in nephropathic cystinosis, Arch. Ophthalmol. 104:706-711.PubMedGoogle Scholar
  51. Kaiser-Kupfer, M. I., Fujikawa, L., Kuwabara, T., and Gahl, W. A., 1987, Removal of corneal crystals by topical cysteamine in nephropathic cystinosis, N. Engl. J. Med. 316:775-779.PubMedCrossRefGoogle Scholar
  52. Kaiser-Kupfer, M. I., Gazzo, M. A., Datiles, M. B., Caruso, R. C., Kuehl, E. M., and Gahl, W. A., 1990, A randomized placebo-controlled trial of cysteamine eyedrops in nephropathic cystinosis, Arch. Ophthalmol. 108:689-693.PubMedGoogle Scholar
  53. Kalatzis, V., Cherqui, S., Antignac, C., and Gasnier, B., 2001, Cystinosin, the protein defective in cystinosis, is a H(+)-driven lysosomal cystine transporter, EMBO J. 20:5940-5949.CrossRefPubMedGoogle Scholar
  54. Kalatzis, V., Cohen-Solal, L., Cordier, B., Frishberg, Y., Kemper, M., Nuutinen, E. M., Legrand, E., Cochat, P., and Antignac, C., 2002, Identification of 14 novel CTNS mutations and characterization of seven splice site mutations associated with cystinosis, Hum Mutat. 20:439-446.CrossRefPubMedGoogle Scholar
  55. Kalatzis, V., Nevo, N., Cherqui, S., Gasnier, B., and Antignac, C., 2004, Molecular pathogenesis of cystinosis: effect of CTNS mutations on the transport activity and subcellular localization of cystinosin, Hum. Mol. Genet. 13:1361-1371.CrossRefPubMedGoogle Scholar
  56. Kiehntopf, M., Schickel, J., Gonne, B., Koch, H. G., Superti-Furga, A., Steinmann, B., Deufel, T., and Harms, E., 2002, Analysis of the CTNS gene in patients of German and Swiss origin with nephropathic cystinosis, Hum. Mutat. 20:237.CrossRefPubMedGoogle Scholar
  57. Kimonis, V. E., Troendle, J., Yang, M. L., Rose, S. R., Markello, T. C., and Gahl, W. A., 1995, Effects of early cysteamine therapy on thyroid function and growth in nephro-pathic cystinosis, J. Clin. Endocrinol. Metab. 80:3257-3261.CrossRefPubMedGoogle Scholar
  58. Kleta, R., and Gahl, W. A., 2002, Cystinosis: antibodies and healthy bodies, J. Am. Soc. Nephrol. 13:2189-2191.CrossRefPubMedGoogle Scholar
  59. Kleta, R., and Gahl, W. A., 2004b, Pharmacological treatment of nephropathic cystinosis with cysteamine, Expert Opin. Pharmacother. 5:2255-2262.Google Scholar
  60. Kleta, R., Anikster, Y., Lucero, C., Shotelersuk, V., Huizing, M., Bernardini, I., Park, M., Thoene, J., Schneider, J., and Gahl, W. A., 2001, CTNS mutations in African American patients with cystinosis, Mol. Genet. Metab. 74:332-337.CrossRefPubMedGoogle Scholar
  61. Kleta, R., Bernardini, I., Ueda, M., Varade, W. S., Phornphutkul, C., Krasnewich, D., and Gahl, W. A., 2004a, Long-term follow-up of well-treated nephropathic cystinosis patients, J. Pediatr. 145:555-560.CrossRefGoogle Scholar
  62. Kleta, R., Blair, S. C., Bernardini, I., Kaiser-Kupfer, M. I., and Gahl, W. A., 2004c, Keratopathy of multiple myeloma masquerading as corneal crystals of ocular cystinosis, Kleta, R., Kaskel, F., Dohil, R., Goodyer, P., Guay-Woodford, L. M., Harms, E., Ingelfinger, J. R., Koch, V. H., Langman, C. B., Leonard, M. B., Mannon, R. B., Sarwal, M., Schneider, J. A., Skovby, F., Sonies, B. C., Thoene, J. G., Trauner, D. A., and Gahl, W. A., 2005, First NIH/Office of Rare Diseases Conference on Cystinosis: past, present, and future, Pediatr. Nephrol. 20:452-454.Google Scholar
  63. Lignac, G. O. E., 1924, Über Störung des Cystinstoffwechsels bei Kindern, Deut. Arch. Klin. Med. 145:139-150.Google Scholar
  64. Markello, T. C., Bernardini, I. M., and Gahl, W. A., 1993, Improved renal function in children with cystinosis treated with cysteamine. N. Engl. J. Med. 328:1157-1162.CrossRefPubMedGoogle Scholar
  65. Mason, S., Pepe, G., Dall’Amico, R., Tartaglia, S., Casciani, S., Greco, M., Bencivenga, P., Murer, L., Rizzoni, G., Tenconi, R., and Clementi, M., 2003, Mutational spectrum of the CTNS gene in Italy, Eur. J. Hum. Genet. 11:503-508.CrossRefPubMedGoogle Scholar
  66. McGowan-Jordan, J., Stoddard, K., Podolsky, L., Orrbine, E., McLaine, P., Town, M., Goodyer, P., MacKenzie, A., and Heick, H., 1999, Molecular analysis of cystinosis: probable Irish origin of the most common French Canadian mutation, Eur. J. Hum. Genet. 7:671-678. Med. Lett. Drugs Ther.,1994, Cysteamine for cystinosis, 36:118.CrossRefPubMedGoogle Scholar
  67. O’Brien, K., Hussain, N., Warady, B. A., Kleiner, D. E., Kleta, R., Bernardini, I., Heller, T., and Gahl, W. A., 2006, Nodular regenerative hyperplasia and severe portal hypertension in cystinosis, Clin. Gastroenterol. Hepatol. 4:387-394.CrossRefPubMedGoogle Scholar
  68. Oshima, R. G., Willis, R. C., Furlong, C. E., and Schneider, J. A., 1974, Binding assays for amino acids. The utilization of a cystine binding protein from Escherichia coli for the determination of acid-soluble cystine in small physiological samples, J. Biol. Chem. 249:6033-6039.PubMedGoogle Scholar
  69. Oude Elferink, R. P., Harms, E., Strijland, A., and Tager, J. M., 1983, The intralysosomal pH in cultured human skin fibroblasts in relation to cystine accumulation in patients with cystinosis, Biochem. Biophys. Res. Commun. 116:154-161.CrossRefPubMedGoogle Scholar
  70. Park, M., Helip-Wooley, A., and Thoene, J., 2002, Lysosomal cystine storage augments apoptosis in cultured human fibroblasts and renal tubular epithelial cells, J. Am. Soc. Nephrol. 13:2878-2887.CrossRefPubMedGoogle Scholar
  71. Park, M. A., and Thoene, J. G., 2005, Potential role of apoptosis in development of the cystinotic phenotype, Pediatr. Nephrol. 20:441-446.CrossRefPubMedGoogle Scholar
  72. Patrick, A. D., and Lake, B. D., 1968, Cystinosis: Electron microscopic evidence of lysosomal storage of cystine in lymph node, J. Clin. Pathol. 21:571-575.CrossRefPubMedGoogle Scholar
  73. Phornphutkul, C., Anikster, Y., Huizing, M., Braun, P., Brodie, C., Chou, J. Y., and Gahl, W .A., 2001, The promoter of a lysosomal membrane transporter gene, CTNS, binds Sp-1, shares sequences with the promoter of an adjacent gene, CARKL, and causes cystinosis if mutated in a critical region, Am. J. Hum. Genet. 69:712-721.CrossRefPubMedGoogle Scholar
  74. Pisoni, R. L., Thoene, J. G., and Christensen, H. N., 1985, Detection and characterization of carrier-mediated cationic amino acid transport in lysosomes of normal and cystinotic human fibroblasts, J. Biol. Chem. 260:4791-4798.PubMedGoogle Scholar
  75. Reiss, R. E., Kuwabara, T., Smith, M. L., and Gahl, W. A., 1988, Successful pregnancy despite placental cystine crystals in a woman with nephropathic cystinosis, N. Engl. J. Med. 319:223-226.PubMedCrossRefGoogle Scholar
  76. Rupar, C. A., Matsell, D., Surry, S., and Siu, V., 2001, A G339R mutation in the CTNS gene is a common cause of nephropathic cystinosis in the south western Ontario Amish Mennonite population, J. Med. Genet. 38:615-616.CrossRefPubMedGoogle Scholar
  77. Schneider, J. A., 1995, Approval of cysteamine for patients with cystinosis, Pediatr. Nephrol. 9:254.CrossRefPubMedGoogle Scholar
  78. Schneider, J. A., 2004, Treatment of cystinosis: Simple in principle, difficult in practice, J. Pediatr. 145:436-438.CrossRefPubMedGoogle Scholar
  79. Schneider, J. A., Bradley, K., and Seegmiller, J. E., 1967, Increased cystine in leukocytes from individuals homozygous and heterozygous for cystinosis, Science 157:1321-1322.CrossRefPubMedGoogle Scholar
  80. Schulman, J. D., Bradley, K. H., and Seegmiller, J. E., 1969, Cystine: Compartmentali-zation within lysosomes in cystinotic leukocytes. Science 166:1152-1154.CrossRefPubMedGoogle Scholar
  81. Shotelersuk, V., Larson, D., Anikster, Y., McDowell, G., Lemons, R., Bernardini, I., Guo, J., Thoene, J., and Gahl, W. A., 1998, CTNS mutations in an American-based population of cystinosis patients, Am. J. Hum. Genet. 63:1352-1362.CrossRefPubMedGoogle Scholar
  82. Smith, M. L., Pellett, O. L., Cass, M. M., Kennaway, N. G., Buist, N. R., Buckmaster, J., Golbus, M., Spear, G. S., and Schneider, J. A., 1987, Prenatal diagnosis of cystinosis utilizing chorionic villus sampling, Prenat. Diagn. 7:23-26.CrossRefPubMedGoogle Scholar
  83. Smolin, L. A., Clark, K. F., and Schneider, J. A., 1987, An improved method for heterozygote detection of cystinosis, using polymorphonuclear leukocytes, Am. J. Hum. Genet. 41:266-275.PubMedGoogle Scholar
  84. Sonies, B. C., Almajid, P., Kleta, R., Bernardini, I., and Gahl, W. A., 2005, Swallowing dysfunction in 101 patients with nephropathic cystinosis; Benefit of long-term cysteamine therapy, Medicine 84:137-146.CrossRefPubMedGoogle Scholar
  85. Sonies, B. C., Ekman, E. F., Andersson, H. C., Adamson, M. D., Kaler, S. G., Markello, T. C., and Gahl, W. A., 1990, Swallowing dysfunction in nephropathic cystinosis, N. Engl. J. Med. 323:565-570.PubMedCrossRefGoogle Scholar
  86. Soohoo, N., Schneider, J. A., and Kaplan, R. M., 1997, A cost-effectiveness analysis of the orphan drug cysteamine in the treatment of infantile cystinosis, Med. Decis. Making 17:193-198.CrossRefPubMedGoogle Scholar
  87. Tenneze, L., Daurat, V., Tibi, A., Chaumet-Riffaud, P., and Funck-Brentano, C., 1999, A study of the relative bioavailability of cysteamine hydrochloride, cysteamine bitartrate and phosphocysteamine in healthy adult male volunteers, Br. J. Clin. Pharmacol. 47:49-52.CrossRefPubMedGoogle Scholar
  88. The Cystinosis Collaborative Research Group, 1995, Linkage of the gene for cystinosis to markers on the short arm of chromosome 17, Nat. Genet. 10:246-248.CrossRefGoogle Scholar
  89. Theodoropoulos, D. S., Krasnewich, D., Kaiser-Kupfer, M. I., and Gahl, W. A., 1993, Classical nephropathic cystinosis as an adult disease, JAMA 270:2200-2204.CrossRefPubMedGoogle Scholar
  90. Thoene, J., Lemons, R., Anikster, Y., Mullet, J., Paelicke, K., Lucero, C., Gahl, W., Schneider, J., Shu, S. G., and Campbell, H. T., 1999, Mutations of CTNS causing intermediate cystinosis, Mol. Genet. Metab. 67:283-293.CrossRefPubMedGoogle Scholar
  91. Thoene, J. G., Oshima, R. G., Crawhall, J. C., Olson, D. L., and Schneider, J. A., 1976, Cystinosis. Intracellular cystine depletion by aminothiols in vitro and in vivo, J. Clin. Invest. 58:180-189.CrossRefGoogle Scholar
  92. Touchman, J. W., Anikster, Y., Dietrich, N. L., Maduro, V. V., McDowell, G., Shotelersuk, V., Bouffard, G. G., Beckstrom-Sternberg, S. M., Gahl, W. A., and Green, E. D., 2000, The genomic region encompassing the nephropathic cystinosis gene (CTNS): complete sequencing of a 200-kb segment and discovery of a novel gene within the common cystinosis-causing deletion, Genome Res. 10:165-173.CrossRefPubMedGoogle Scholar
  93. Town, M., Jean, G., Cherqui, S., Attard, M., Forestier, L., Whitmore, S. A., Callen, D. F., Gribouval, O., Broyer, M., Bates, G. P., van't Hoff, W., and Antignac, C., 1998, A novel gene encoding an integral membrane protein is mutated in nephropathic cystinosis, Nat. Genet. 18:319-324.CrossRefPubMedGoogle Scholar
  94. Trauner, D. A., Chase, C., Scheller, J., Katz, B., and Schneider, J. A., 1988, Neurologic and cognitive deficits in children with cystinosis, J. Pediatr. 112:912-914.CrossRefPubMedGoogle Scholar
  95. Trauner, D. A., Fahmy, R. F., and Mishler, D. A., 2001, Oral motor dysfunction and feeding difficulties in nephropathic cystinosis, Pediatr. Neurol. 24:365-368.CrossRefPubMedGoogle Scholar
  96. Tsilou, E. T., Rubin, B. I., Reed, G. F., Iwata, F., Gahl, W., and Kaiser-Kupfer, M. I., 2002, Age-related prevalence of anterior segment complications in patients with infantile nephropathic cystinosis, Cornea 21:173-176.CrossRefPubMedGoogle Scholar
  97. Tsilou, E. T., Thompson, D., Lindblad, A. S., Reed, G. F., Rubin, B., Gahl, W., Thoene, J., Del Monte, M., Schneider, J. A., Granet, D. B., and Kaiser-Kupfer, M. I., 2003, A multicentre randomised double masked clinical trial of a new formulation of topical cysteamine for the treatment of corneal cystine crystals in cystinosis, Br. J. Ophthalmol. 87:28-31.CrossRefPubMedGoogle Scholar
  98. Van’t Hoff, W. G., and Gretz, N., 1995, The treatment of cystinosis with cysteamine and phosphocysteamine in the United Kingdom and Eire, Pediatr. Nephrol. 9:685-689.CrossRefPubMedGoogle Scholar
  99. Wenner, W. J., and Murphy, J. L., 1997, The effects of cysteamine on the upper gastrointestinal tract of children with cystinosis, Pediatr. Nephrol. 11:600-603.CrossRefPubMedGoogle Scholar
  100. Wuhl, E., Haffner, D., Offner, G., Broyer, M., van't Hoff, W., Mehls, O, and European Study Group on Growth Hormone Treatment in Children with Nephropathic Cystinosis, 2001, Long-term treatment with growth hormone in short children with nephropathic cystinosis, J. Pediatr. 138:880-887.Google Scholar

Copyright information

© Springer Science+Business Media, LLC 2007

Authors and Affiliations

  • Amanda Helip-Wooley
    • 1
  • Robert Kleta
    • 1
  • William A. Gahl
    • 1
  1. 1.Section on Human Biochemical Genetics, Medical Genetics BranchNational Human Genome Research Institute, NIHBethesdaUSA

Personalised recommendations